Discovery Life Sciences
Discovery Life Sciences, headquartered in the United States, is a leading provider in the biospecimen and laboratory services industry. Founded in 2013, the company has rapidly established itself as a key player, offering a comprehensive range of services that include biospecimen procurement, biobanking, and advanced laboratory testing. With operational facilities across major regions in the US, Discovery Life Sciences is renowned for its commitment to quality and innovation. Their unique approach combines cutting-edge technology with a deep understanding of the life sciences sector, ensuring that clients receive unparalleled support in their research and development efforts. Notable achievements include a robust portfolio of core products and services that cater to the needs of pharmaceutical, biotechnology, and academic institutions. Discovery Life Sciences continues to solidify its market position through strategic partnerships and a dedication to advancing scientific discovery.
DitchCarbon Score
How does Discovery Life Sciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Discovery Life Sciences's score of 23 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Discovery Life Sciences's reported carbon emissions
Discovery Life Sciences, headquartered in the United States, currently does not report any specific carbon emissions data for the most recent year. However, the company is committed to addressing climate change through various initiatives. Discovery Life Sciences has made a near-term commitment to reduce its carbon footprint, although specific reduction targets have not been disclosed. As part of its climate strategy, the company is engaged with the Science Based Targets initiative (SBTi) and has confirmed its commitment status as "Committed." This indicates that Discovery Life Sciences is actively working towards establishing science-based targets to mitigate its greenhouse gas emissions, although it has not yet set a net-zero target. The company operates within the Pharmaceuticals, Biotechnology, and Life Sciences sector, which is increasingly focusing on sustainability and reducing environmental impact. Discovery Life Sciences' commitment to climate action reflects a growing trend in the industry towards more responsible environmental practices. Overall, while specific emissions data is not available, Discovery Life Sciences is taking steps to align with global climate goals through its commitment to the SBTi.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Discovery Life Sciences is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
